Compulsory enforcement of bioequivalance test eyed

Published: 2002-05-08 07:00:00

Updated: 2002-05-08 07:00:00

The Korea Food and Drug Administration (KFDA) says that it will positively contemplate the mandatory bioequivalance test and drug re-evaluation project on any new licensed items containing ingredients which will be subject to bioequivalence test and to this end, it will draft the relevant regulat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK